Neue Suche | Kongressdetail
mail
Druckansicht
 
 

2nd Rare CNS and Neurodevelopmental Drug Development Summit

Evvnt Promotion / evvnt
-
28.11.2022 - 30.11.2022  Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 8:00 am - 3:50 pm
 
Kongressthemen
With further clinical data emerging, drug development for rare CNS and neurodevelopmental disorders is advancing from hypotheticals to real-life clinical results, outcomes, and functional biomarkers; catapulting this critical field forwards to change patients' lives.

The 2nd Rare CNS and Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups, paving the way towards symptomatic and successful disease
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
URL:
Brochure: https://go.evvnt.com/1289306-3?pid=4832

Speakers: Alfica Sehgal, Senior Vice President, Head of Discovery and Translation, CAMP4 Therapeutics and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/1289306-2?pid=4832
Frau Emily Lincoln
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 2599.00 - USD 5846.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Ärztekammer für WiennewTreeÖsterreichische Akademie der ÄrzteSwiss Tropical and Public Health InstituteAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAlumni Club Medizinische Universität WienCharité International AcademyHelix - Forschung & Beratung Wien